| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $2,188,547 ) |
| | 2024 | 2024 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01CA263196 | Establishing the clinical utility of cell-free tumor DNA methylation profiling as a reliable liquid biopsy approach in brain tumors | 000 | 3 | NIH | 3/8/2024 | $350,776 |
| | 2024 | 2024 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01CA263196 | Establishing the clinical utility of cell-free tumor DNA methylation profiling as a reliable liquid biopsy approach in brain tumors | 001 | 3 | NIH | 4/17/2024 | $19,484 |
| | 2024 | 2024 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01AI173319 | Immunoengineering of donor lungs to optimize long-term graft function | 000 | 1 | NIH | 2/12/2024 | $545,484 |
| | 2024 | 2024 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01CA255670 | Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer. | 000 | 4 | NIH | 4/4/2024 | $352,374 |
| | 2024 | 2024 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | UM1CA186644 | North American Star Consortium | 001 | 8 | NIH | 4/12/2024 | $920,429 |
| | 2024 | 2023 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | UM1CA186644 | North American Star Consortium | 000 | 7 | NIH | 1/10/2024 | $0 |
| | 2024 | 2022 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R03HD104206 | A longitudinal population-based birth cohort study to understand the past, present, and future of children and youth with traumatic brain injury | 000 | 2 | NIH | 11/6/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $4,924,767 ) |
| | 2023 | 2023 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | UM1CA186644 | North American Star Consortium | 009 | 7 | NIH | 9/14/2023 | $341,314 |
| | 2023 | 2023 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01CA263196 | Establishing the clinical utility of cell-free tumor DNA methylation profiling as a reliable liquid biopsy approach in brain tumors | 000 | 2 | NIH | 3/23/2023 | $400,069 |
| | 2023 | 2023 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01AG077481 | Establishing Reference Values and Clinical Decision Points for Quantitative Videofluoroscopic Measures of Swallowing | 000 | 10 | NIH | 8/25/2023 | $913,261 |
| | 2023 | 2023 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | U01HL163298 | CATCH: Creating Access to Transplant for Candidates who are High Risk | 000 | 2 | NIH | 7/21/2023 | $398,700 |
| | 2023 | 2023 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01CA255670 | Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer. | 000 | 3 | NIH | 3/14/2023 | $363,672 |
| | 2023 | 2023 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01HD104553 | Defining the impact of dolutegravir on the maternal metabolic environment and its implications on risk of congenital anomalies. | 000 | 4 | NIH | 5/12/2023 | $263,042 |
| | 2023 | 2023 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | UM1CA186644 | North American Star Consortium | 008 | 7 | NIH | 8/7/2023 | $831,685 |
| | 2023 | 2023 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | UM1CA186644 | North American Star Consortium | 001 | 7 | NIH | 5/9/2023 | $1,259,602 |
| | 2023 | 2023 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | UM1CA186644 | North American Star Consortium | 002 | 7 | NIH | 5/16/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | UM1CA186644 | North American Star Consortium | 004 | 7 | NIH | 6/15/2023 | $505,150 |
| | 2023 | 2023 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | UM1CA186644 | North American Star Consortium | 003 | 7 | NIH | 5/31/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01AI085043 | Mechanisms of Viral Persistence | 000 | 15 | NIH | 6/22/2023 | $324,000 |
| | 2023 | 2022 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | U01CA253383 | Understanding the molecular mechanism of a protein-recycling complex in small cell lung cancer treatment resistance. | 000 | 3 | NIH | 12/21/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | U01CA253383 | Understanding the molecular mechanism of a protein-recycling complex in small cell lung cancer treatment resistance. | 001 | 3 | NIH | 4/26/2023 | $0 |
| | 2023 | 2022 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | UM1CA186644 | North American Star Consortium | 007 | 6 | NIH | 8/7/2023 | -$372,146 |
| | 2023 | 2021 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | UM1CA186644 | North American Star Consortium | 006 | 6 | NIH | 8/7/2023 | -$117,200 |
| | 2023 | 2020 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | UM1CA186644 | North American Star Consortium | 005 | 6 | NIH | 8/7/2023 | -$342,339 |
| | 2023 | 2020 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | UM1CA186644 | North American Star Consortium | 000 | 6 | NIH | 12/8/2022 | $155,956 |
| | 2023 | 2020 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01DC011020 | Physiological Flow of Liquids Used in Dysphagia Management (previously Tongue-Pressure Timing for Liquid Flow Detection and Control in Swallowing) | 000 | 8 | NIH | 5/15/2023 | $0 |
| | 2023 | 2019 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | U01DK082874 | Observation Study of Persons with Chronic Hepatitis B Virus infection in North America | 000 | 11 | NIH | 11/23/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $3,559,558 ) |
| | 2022 | 2022 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | U01HL163298 | CATCH: Creating Access to Transplant for Candidates who are High Risk | 000 | 1 | NIH | 8/5/2022 | $404,700 |
| | 2022 | 2022 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | U01CA253383 | Understanding the molecular mechanism of a protein-recycling complex in small cell lung cancer treatment resistance. | 000 | 3 | NIH | 8/15/2022 | $333,379 |
| | 2022 | 2022 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01CA263196 | Establishing the clinical utility of cell-free tumor DNA methylation profiling as a reliable liquid biopsy approach in brain tumors | 000 | 1 | NIH | 3/21/2022 | $410,441 |
| | 2022 | 2022 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01AG077481 | Establishing Reference Values and Clinical Decision Points for Quantitative Videofluoroscopic Measures of Swallowing | 000 | 9 | NIH | 7/28/2022 | $926,095 |
| | 2022 | 2022 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01CA255670 | Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer. | 000 | 2 | NIH | 4/20/2022 | $369,337 |
| | 2022 | 2022 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01HD104553 | Defining the impact of dolutegravir on the maternal metabolic environment and its implications on risk of congenital anomalies. | 000 | 3 | NIH | 7/1/2022 | $321,745 |
| | 2022 | 2022 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R03HD104206 | A longitudinal population-based birth cohort study to understand the past, present, and future of children and youth with traumatic brain injury | 001 | 2 | NIH | 4/26/2022 | $9,772 |
| | 2022 | 2022 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R03HD104206 | A longitudinal population-based birth cohort study to understand the past, present, and future of children and youth with traumatic brain injury | 000 | 2 | NIH | 11/30/2021 | $87,943 |
| | 2022 | 2022 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | UM1CA186644 | North American Star Consortium | 000 | 6 | NIH | 9/13/2022 | $372,146 |
| | 2022 | 2022 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01AI085043 | Mechanisms of Viral Persistence | 002 | 14 | NIH | 7/14/2022 | $324,000 |
| | 2022 | 2020 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01CA190449 | The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development | 000 | 6 | NIH | 10/13/2021 | $0 |
| | 2022 | 2020 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | UM1CA186644 | North American Star Consortium | 001 | 6 | NIH | 9/14/2022 | $0 |
| | 2022 | 2020 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01AI085043 | Mechanisms of Viral Persistence | 001 | 12 | NIH | 6/24/2022 | $63,215 |
| | 2022 | 2019 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | U01DK082874 | Observation Study of Persons with Chronic Hepatitis B Virus infection in North America | 000 | 11 | NIH | 11/1/2021 | $0 |
| | 2022 | 2019 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01AI085043 | Mechanisms of Viral Persistence | 000 | 11 | NIH | 6/24/2022 | -$63,215 |
| | 2022 | 2018 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R61MH110034 | The DMPFC as a target in treatment-resistant Bulimia Nervosa and Anorexia Nervosa:investigating target engagement, dosing, reliability and duration of effect using rTMS, fMRI,and a sham controlled arm | 000 | 2 | NIH | 10/27/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,566,724 ) (Continued on the next page) |
| | 2021 | 2021 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01HD104553 | Defining the impact of dolutegravir on the maternal metabolic environment and its implications on risk of congenital anomalies. | 001 | 2 | NIH | 6/28/2021 | $346,219 |
| | 2021 | 2021 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | U01CA253383 | Understanding the molecular mechanism of a protein-recycling complex in small cell lung cancer treatment resistance. | 000 | 2 | NIH | 8/10/2021 | $295,362 |
| | 2021 | 2021 | UNIVERSITY HEALTH NETWORK | 200 ELIZABETH ST | TORONTO | ON | | | CAN | R01CA255670 | Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer. | 000 | 1 | NIH | 4/26/2021 | $376,878 |
|
